Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

51 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

Courts Find Gilead "Morally Blameworthy" for Withholding HIV Medication

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
California's Court of Appeals denies Gilead Sciences' request for immunity from liability

BALTIMORE, MD, January 23, 2024 /24-7PressRelease/ -- In a pivotal decision, the California Court of Appeal rejected Gilead Sciences' bid for immunity from liability in a case involving its HIV medications. This ruling represents a critical juncture in the ongoing legal dispute over Gilead's management of its HIV antiretroviral drugs, particularly the delayed release of tenofovir alafenamide (TAF), a safer alternative to its existing medication, tenofovir disoproxil fumarate (TDF).

The Court's comprehensive 62-page opinion firmly denounces Gilead's approach, highlighting the company's alleged strategy to maximize profits from TDF at the expense of patient safety. The California Court of Appeal's decision clarifies that Gilead had a legal duty to avoid foreseeable harm to the users of its medications, rebuking the pharmaceutical giant's rejection of that obligation.

The case, which involves more than 22,000+ lawsuits consolidated in a mass tort action, accuses Gilead of intentionally delaying the development of TAF despite being aware of its safer profile compared to TDF. The extensive discovery phase of the litigation revealed internal documents suggesting Gilead could have released TAF significantly earlier than its eventual 2015 U.S. Food and Drug Administration (FDA) approval, thereby preventing harm to patients. The prolonged exposure to TDF significantly increased the risks to kidney and bone health.

The Court found Gilead's actions "morally blameworthy," emphasizing the ethical implications of their decision-making process.

Co-lead counsel Robert K. Jenner of Jenner Law has been instrumental in bringing these allegations to light. He has reaffirmed its commitment to seeking justice for those adversely affected by TDF, emphasizing the importance of holding corporations accountable for their actions.

About Jenner Law

Jenner Law is a nationally recognized personal injury law firm renowned for its commitment to representing individuals in life-altering injury cases. With offices in Maryland, Virginia, and Massachusetts, the firm specializes in complex cases involving dangerous drugs and medical devices, sexual abuse, and general negligence.

Led by Robert K. Jenner, one of "America's 55 Most Influential Trial Lawyers," the firm has established itself at the forefront of significant legal battles, including the high-profile case against Gilead Sciences over its HIV medication.

The Jenner Law team includes accomplished attorneys Katie Kerner and Elisha Hawk and offers expertise in a range of areas, from sexual abuse lawsuits, including clergy and therapist abuse, to personal injury cases involving catastrophic injuries and environmental pollutants.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.22
+0.00 (0.00%)
AAPL  301.54
+0.00 (0.00%)
AMD  490.33
+0.00 (0.00%)
BAC  53.63
+0.00 (0.00%)
GOOG  361.17
+0.00 (0.00%)
META  585.39
+0.00 (0.00%)
MSFT  411.74
+0.00 (0.00%)
NVDA  208.64
+0.00 (0.00%)
ORCL  211.82
+0.00 (0.00%)
TSLA  408.95
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.